Skip to content

Clinical trials

Phase 3 Peripheral Arterial Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Arterial Disease Phase: Phase 3 Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20052
20062
20073
20082
20095
20102
20115
20124
20131
20141
20155
20164
20175
20183
20193
20202
20213
20222
20231
20241
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Recruiting9
Unknown status7
Terminated5
Not yet recruiting2
Active, not recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Northwestern University7
Bayer3
Abbott Medical Devices2
Eli Lilly and Company2
Ixaka Ltd2
Kos Pharmaceuticals2
Sanofi2
University Hospital, Grenoble2
Alvogen Korea1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Arterial Disease66
Peripheral Vascular Diseases14
Atherosclerosis12
Intermittent Claudication11
Cardiovascular Diseases7
Chronic Limb-Threatening Ischemia6
Diabetes Mellitus, Type 25
Stroke5
Coronary Artery Disease4
Diabetes Mellitus4

Trials

Showing 76 to 66 of 66. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.